PURASORB PDLG 5004A is a poly(DL-lactide-co-glycolide) copolymer with a nominal lactide:glycolide molar ratio of 50:50 and acid-terminated chain ends. The material is supplied as a white to off-white granular solid for solvent-based drug delivery processes, including microspheres, nanoparticles, and in situ forming depots. Inherent viscosity is controlled within 0.38–0.48 dL/g for a 0.1 g/dL solution in chloroform at 25 °C. This viscosity range corresponds to a moderate molar mass that preserves organic-phase processability while providing matrix integrity during the early release phase. Terminal carboxylic acid groups differentiate this grade from ester-terminated or capped PLGA products and influence hydration, degradation kinetics, and peptide adsorption. Published application data are concentrated in emulsion-based microencapsulation and solvent-evaporation processes; data for continuous melt-based manufacturing with this exact acid-terminated grade are limited.

What Release Specifications Define PURASORB PDLG 5004A?

The specification is defined by viscosity, comonomer ratio, and end-group variables. Inherent viscosity is measured using an Ubbelohde viscometer according to ISO 1628-1:2021 at 25 °C in chloroform at 0.1 g/dL. The nominal lactide:glycolide molar ratio is 50:50. Certificates of analysis document residual lactide, glycolide, residual solvents, and elemental impurities. Storage at −18 °C to −25 °C under dry inert gas is recommended; repeated warming above the glass transition can cause particle sintering and moisture uptake. Residual solvent reporting is aligned to USP Chapter 467 and Ph. Eur. 2.4.24. Elemental impurities are reported according to ICH Q3D. If the material is intended for parenteral use, bacterial endotoxin testing according to Ph. Eur. 2.6.14 may be required by the downstream user. Moisture content should be determined by Karl Fischer titration before melt processing; control below 0.5 wt% minimizes hydrolytic degradation during thermal steps. Because the lactide monomer is racemic D,L-lactide, the copolymer is amorphous and shows no crystalline melting endotherm by differential scanning calorimetry; the glass transition typically appears near 43–48 °C at a heating rate of 10 °C/min under nitrogen.

Acid Termination and Hydrolytic Degradation Kinetics

Acid-terminated PLGA hydrates more rapidly than an ester-terminated copolymer of equivalent lactide:glycolide ratio and inherent viscosity when exposed to neutral aqueous buffer at 37 °C. The terminal carboxylic acid groups increase local water binding and autocatalyze ester hydrolysis; mass loss and release of lactic and glycolic acid units accelerate relative to methyl- or lauryl-capped grades. In monolithic implants thicker than 100 µm, this autocatalysis can create an internal pH gradient and heterogeneous degradation. In microspheres or nanoparticles with diffusion distances below 20 µm, the effect is attenuated because acidic degradation products diffuse outward more rapidly. Acid termination also provides deprotonated carboxylate surface charge at physiological pH, which can adsorb cationic peptides, proteins, or oligonucleotides during emulsion loading. This property improves loading for some positively charged active compounds but can increase surface-associated release if the formulation lacks a buffering excipient or divalent cationic additive. Ester-terminated PLGA of the same 0.4 dL/g viscosity class is generally selected when a longer hydrolysis induction period or reduced acid-driven incompatibility is required.

For o/w microsphere production, a representative batch process disperses 4.0 g of PURASORB PDLG 5004A in 12 mL of dichloromethane and emulsifies the organic phase into 120 mL of 1 wt% poly(vinyl alcohol) solution at 15 °C. A rotor-stator mixer with tip speed of 8–12 m/s applied for 60–90 s yields mean particle sizes in the 20–60 µm range. The emulsion is transferred to a hardening bath containing 0.1 wt% poly(vinyl alcohol) and stirred at 300 rpm for 4 h to extract dichloromethane and consolidate particles. Poly(vinyl alcohol) with degree of hydrolysis 87–89 % and weight-average molar mass 13,000–23,000 g/mol is commonly used; lower hydrolysis grades can leave surface-active residues on the particle surface. Residual dichloromethane is controlled below the ICH Q3C Class 2 limit of 600 ppm by vacuum drying at 25 °C for at least 24 h. Batch high-shear emulsification typically produces a particle size span above 1.4–1.8; membrane emulsification or microfluidic solvent extraction is required when a span below 1.1 is specified. During scale-up from 1 L to 100 L emulsion vessels, rotor-stator tip speed and energy dissipation density must be matched rather than impeller speed alone to maintain equivalent shear history.

For solvent displacement nanoprecipitation, PURASORB PDLG 5004A is dissolved in acetone or tetrahydrofuran at 5–10 mg/mL and injected into an aqueous stabilizer phase at 4 °C at an organic flow rate below 2 mL/min. The terminal carboxylic acid groups produce a negative zeta potential at pH 7.4; electrophoretic light scattering typically reports values between −20 mV and −40 mV depending on residual stabilizer. Nanoparticle mean diameters below 200 nm are achievable by solvent displacement, but aseptic filtration of nanoparticles is possible through 0.22 µm membranes only when the mean diameter is substantially below the pore size. The product can also be dissolved at 30–40 wt% in N-methyl-2-pyrrolidone for in situ forming implant formulations; injectability through a 21 G needle requires dynamic viscosity below 1,500 mPa·s at 25 °C. Residual water in such formulations must be kept below 0.5 wt% to prevent premature hydrolysis during storage. Ultrasonication-based nanoparticle production with a probe sonicator at 20 kHz and 50 W output for 30–60 s is feasible, but titanium probe wear can introduce trace metal contamination requiring ICH Q3D assessment.

When Melt Extrusion or Terminal Sterilization Is Applied to Acid-Terminated PLGA

Acid-terminated PLGA has a glass transition below 50 °C and a restricted thermal processing window. Vacuum drying at 25 °C for 24–48 h before melt processing reduces moisture-induced hydrolysis. A co-rotating twin-screw extruder with L/D ratio of 25:1 to 30:1 and barrel temperatures between 80 °C and 110 °C can plasticize the copolymer, but acidic end groups accelerate ester cleavage above 120 °C. Screw speeds above 150 rpm may generate shear heating beyond the set barrel temperature and reduce molar mass. Terminal sterilization by gamma irradiation at 25 kGy causes chain scission and lowers inherent viscosity; ISO 11137 validation must demonstrate retained release kinetics and molar mass after the maximum dose. Ethylene oxide is generally unsuitable for acid-terminated PLGA microspheres because residual moisture and reactive carboxyl groups can retain ethylene oxide residues; if used, ISO 10993-7 limits must be confirmed. Published data for melt-processed PURASORB PDLG 5004A are limited, and solution-based microencapsulation remains the reference process for this grade.

Analytical release documentation for PURASORB PDLG 5004A is aligned to parenteral excipient and drug product requirements. Residual solvent testing follows USP Chapter 467, with dichloromethane controlled below 600 ppm and other Class 2 solvents controlled according to ICH Q3C. Elemental impurity data are reported under ICH Q3D. In vitro cytotoxicity testing according to ISO 10993-5 is performed on the polymer or the finished device to support biocompatibility. The polymer is not terminally sterilized as supplied; downstream processing must include aseptic filtration for nanoparticles, aseptic spray-drying, or validated terminal sterilization after encapsulation. Acid-terminated PLGA can adsorb to size exclusion chromatography columns when chloroform alone is used; the mobile phase is often modified with 0.1 % trifluoroacetic acid or replaced with hexafluoroisopropanol and light scattering to avoid carboxylate adsorption. Acid number by titration differentiates acid-terminated from ester-terminated product and is batch-specific; titration is performed in tetrahydrofuran with methanolic potassium hydroxide using phenolphthalein detection. If residual organic solvent exceeds the applicable ICH Q3C limit, vacuum drying is extended and residual solvent content is remeasured before release. Polymer batches with lower acid numbers within the certificate-of-analysis range may exhibit slightly slower degradation; release profiles must be confirmed for each lot when in vivo performance is critical.

Microsphere Release Variability and Batch-to-Batch Control

Release from PLGA microspheres depends on comonomer sequence, residual monomers, porosity, and particle size. Within the permitted inherent viscosity band, batch-to-batch variation in acid number or residual monomer can shift the 24 h initial release and the 7-day lag phase. Residual lactide and glycolide above 0.5 wt% plasticize the matrix and increase the initial burst. Porosity is controlled by the organic solvent removal rate; rapid extraction at 30 °C can create open pores and accelerate release, while slow extraction at 15 °C produces denser particle skins. Process scale-up must preserve the same droplet breakup mechanism; otherwise, a larger mean particle size increases total release duration. Gamma irradiation after encapsulation reduces molar mass and may remove the lag phase, requiring re-qualification of the release specification. If a formulation exhibits excessive initial release, addition of a divalent cation or basic additive may modulate carboxylate interactions, but such additives must be evaluated for incompatibility with the active ingredient.

Compared with lower inherent viscosity PLGA in the 0.16–0.24 dL/g range, PURASORB PDLG 5004A provides higher matrix molar mass, lower initial burst, and slower mass loss, and is generally used for depot formulations with a nominal duration of 1–3 months. Higher inherent viscosity grades in the 0.8–1.2 dL/g range extend release but require more organic solvent or higher processing temperature, increasing residual solvent and hydrolytic risk. Compared with ester-terminated PLGA of equivalent viscosity, PURASORB PDLG 5004A displays faster hydration, shorter degradation induction, and greater interaction with cationic active compounds. It should not be blended with amine-containing additives or alkaline buffers without controlled pH adjustment; terminal carboxyl groups can form salts or promote ester aminolysis, resulting in uncontrolled molar mass loss during storage. For release beyond 4 months, 75:25 lactide:glycolide acid-terminated grades are commonly selected; for release below 1 month, 0.2 dL/g 50:50 grades are typically specified. Each downstream process must establish release, residual solvent, and molar mass acceptance criteria against the specific sterilization and drug-loading conditions.